Twocases of acquired immunodeficiencysyndromewith myelodysplasia are presented. Case 1 was admitted because of Pneumocystis carinii pneumonia. Mild anemia, thrombocytopenia and hypersegmented neutrophils were observed. After the administration of trimethoprim-sulfamethoxazole and antiretroviral therapy, pancytopenia progressed. Bone marrow (BM) showed dysplastic hematopoiesis, suggesting human immunodeficiency virus-myelopathy. Case 2 was hospitalized due to progressive multifocal leukoencephalopathy. BMspecimen obtained for thrombocytopenia showed myelodysplasia similar to myelodysplastic syndrome, suggesting that HIVmayhave an influence on hematopoietic progenitor cells. (Internal Medicine 40: 795-801, 2001) 
Introduction
Hematologicabnormalities are found in most patients with human immunodeficiency virus (HIV) infection ( 1 , 2), particularly in later phases of the disease. Anemia, leukopenia, thrombocytopenia or pancytopenia are often observed. However, the causes of these abnormalities are usually multifactorial, and commonlycan be attributed to hematopoietic suppression of bone marrowdue to infection or drugs. Dysplastic hematopoiesis is also a commonfinding accompanying HIV infection (3, 4) . If the well-defined criteria for the diagnosis of myelodysplastic syndrome (MDS) are applied, most hemopoietic findings in acquired immunodeficiency syndrome (AIDS) do not correspond to the significant maturation defects comparable with MDS.In a large number of cases, bone marrow (BM) findings seem to be nonspecifically abnormal. Therefore, bone marrowlesions accompanying AIDSmay be separated from MDSand diagnosed as HIV-myelopathy. In this article we report two cases of AIDSwith dysplastic hematopoiesis. HIVinfection may induce HIV-myelopathy, or MDSresults from the influence on hematopoietic progenitor cells (HPC), and MDScontributes to peripheral pancytopenia through ineffective hematopoiesis.
Case Report Case1
A 66-year-old manwas admitted to our hospital on October 8, 1998, because of severe pneumonia. He had no past history except for hepatitis B. On admission, laboratory data showed mild normochromic anemia (hemoglobin 1 2.0 g/dl) and thrombocytopenia (platelet count 9.6xlO4/|il). The white blood cell (WBC)count was 6,000/|iil, and the differential revealed 73%neutrophils and 1 6% lymphocytes.Hypersegmentationof the neutrophils wasobserved. The levels of lactic acid dehydrogenase (LDH)(1 ,249 IU), C-reactive protein (CRP)(18.2 mg/dl) and (l->3)-p-Dglucan (>300 pg/ml) were elevated. Analysis of arterial blood gas showed that the partial pressure of oxygen was 49.8 Torr, the partial pressure of carbon dioxide was 27.7 Torr, and pH was 7.465. Chest radiograph and chest computed tomography (CT) showed diffuse interstitial infiltrations. Pneumocystis carinii was detected from the bronchoalveolar lavage (BAL) fluid by Grocott staining and polymerase chain reaction (PCR). As HIV-1, 2 antibodies and Western blotting for HIV-1 antibody were both positive, he was diagnosed as having acquired immunodeficiency syndrome (AIDS) complicated with Pneumocystis carinii pneumonia (PCP). The CD4+cell count was 37/|il and HIV-1-RNA viral load was 8.6xlO4 copies/ml.
Trimethoprim and sulfamethoxazole (TMP-SMX) with glucocorticoid therapy was effective, and PCPwas improved. After about 1 month, highly active antiretroviral therapy (HAART), that is, zidovudine, lamivudine and nelfinavir was started. As WBCcount was decreased to l,300/|il (neutrophils 9%) on November 9, granulocyte colony-stimulating factor (G-CSF) was administered. On November 12, he suffered from pneumonia again. Culture of BALfluid yielded Aspergillusflavus. As the pneumonia was improved by the administration of amphotericin B, he was discharged on February 2, 1999 (Fig. 1) . As pancytopenia (WBC2,700/|il, neutrophils 9%, hemoglobin 10.4 g/dl, MCV1 14.2 fl, platelet 7.3xlO4/^l) developed, bone marrow (BM) was examined on February 22, 1999. Although BMcellularity was normal, morphologic abnormalities of giant stab, hypersegmentation and defective granulation of neutrophils, distorted nuclear and cytoplasmic maturation, multinucleation of erythroblasts were observed (Fig. 2) . Chromosomeanalysis was 46, XY. The serum levels of vitamin B 12 and folic acid were in the normal range.
Case2
A 25-year-old man complained of fever on October 13, 1997 and one week later, language disturbance and difficulty with handwriting appeared. He was admitted to our hospital on November 5. He had been diagnosed as having HIV infection, and zidovudine had been administered in another hospital in December1994. Whenhe came to our out-patient clinic in November 1996, CD4+cell count was 39/jLtl and platelet count, 7.5x l O4/| Lil.
On admission, he did not show abnormal neurologic findings except for slight ataxia on the right upper extremities. His WBCcount was 3,400/|Lil and the differential revealed 38% neutrophils and 44%lymphocytes. He showed thrombocytopenia (platelet count 6. lxl0V|il) without anemia. CD4+ cell count was 91/jj.I, and HIV-1-RNA viral load was 5.5xlO4 copies/ml. The culture of cerebrospinal fluid (CSF) was negative. A T2-weighted magnetic resonance imaging (MRI) showed an increased high intensity signal in the white matter of bilateral frontal lobe. Didanosine and indinavir were started. At the end of November 1997, he showed hemiparesis on the right side.
Platelet count was decreased to 4.5x104/|nl. 9.0-25.0). CD4+ cell count was 112/^1 and viral load was less than 400 copies/ml. The serum level of vitamin B 12 was high and folic acid was in the normal range. JC virus was detected from the CSF by PCR. He was diagnosed as having progressive multifocal leukoencephalopathy. BMaspirates were obtained for the examination of thrombocytopenia. BMspecimen demonstrated slightly hypercellular marrow and morphologic abnormalities of hypo-or hypersegmentation, reduced or absent granulation of neutrophils, distorted nuclear and cytoplasmic maturation, and multinucleation of erythroblasts (Fig.  3) . Neutrophil alkaline phosphatase (NAP) score was diminished to 139 (control 405). Chromosome analysis was 46, XY. These findings were similar to MDS.Although CD4+cell count was increased to 268/jj.l, his neural findings rapidly worsened and dysphagia appeared. After antiretroviral therapy was stopped, peripheral pancytopenia gradually progressed. WBC count was 1,300/jj,1 (neutrophils 61, lymphocytes 29%), hemoglobin 5. 1 g/dl and platelet count 2.3xlO4/|il in July 1998. BM aspirates were obtained, and the findings were similar to the last one. He suffered from sepsis repeatedly {Staphylococcus epidermidis, Candida albicans, Pseudomonas aeruginosa, Citrobacterfrenndii, Enterococcus faecalis, methicillin resistant Staphylococcus aureus) (Fig. 4) . tion of auxiliary cells, mainly macrophages and microvascular endothelialcells (MVEC) (5) and viral gene products can indirectly influence survival and growth of HPC. The production of hematopoietic growth factors by HIV infected-auxiliary cells is normal,but lipopolysaccharide (LPS)-induced production of granulocyte-macrophage colony-stimulating factor (CSF), macrophage-CSF, G-CSF, interleukin (IL)-l or IL-6 is significantly reduced (6). Moreover HIV inhibits replication of HPC by inducing release of multiple mitotic inhibitory factors (7, 8) and expression of factors knownto induce apoptosis (9). These mechanisms can cause peripheral pancytopenia in association with BMfailure. However, these studies have not suggested that HIV causes myelodysplasia or MDS. On the other hand, myelodysplasia is also a commonfinding accompanying HIV infection. As dysplastic hematopoiesis in AIDS patients usually seems to be nonspecific change, it is called HTV-myelopathy. Cases of ADDS complicated with MDS seem to be rare (10, ll). As most patients with AIDS have already received myelotoxic therapy prior to marrowexamination, it is difficult to specify the cause of dysplastic hematopoiesis. In other words, it is possible that the dysplastic changes could be related to drugs or infections. Inoue et al showed that long-term exposure of zidovudine produces myelodysplasia in mice (12). It is generally assumed that DNA elongation is stopped by the insertion of zidovudine into the chain in place of thymidine and therefore possible to link to the qualitative abnormalityof HPC. Gancyclovir and TMP-SMX have not been reported to cause myelodysplasia. Viral infections usually can cause cytopenias in association with BM suppression. There are a few reports which discuss myelodysplasia caused by viral infection. Baurmannet al reported that bone marrowinfection by parvovirus B 19 could closely mimic myelodysplasia (13) .
Wereported two cases of myelodysplasia associated with AIDS. In case 1, mild anemia, thrombocytopenia and hypersegmentedneutrophils were observed before the admin- NAP score was diminished. Peripheral pancytopenia has gradually progressed after discontinuation of antiretroviral therapy. These findings were similar to MDS (Table 1) . chronic myelomonocytic leukemia and refractory anemia with excess of blasts in transformation). In contrast to the inconspicuous changes of hemopoietic cells in AIDS, MDS showed a variety of morphologic abnormalities (3, 4). Because MDS results from an abnormality of HPC, it is very important to focus on the direct influence of HIV on HPC (14). Current studies suggest that HIV infection of HPC is infrequent and not substantially involved in the pathogenesis of marrow failure. However, it has already been shown that a small fraction of enriched marrow progenitors express both CD34+ and either CD4+ or gpl20+ (15). Recently, it was shown that CXCR4 transcripts were detected in CD34+ cells (16). We observed that pathogenic simian/human immunodeficiency virus (SHIV) induced dysplastic hematopoiesis which might result from the effect on HPC (Yoshino N et al, manuscript in preparation) . Based on these facts, HPC may be infectable under certain conditions. Although thrombocytopenia is not common as an isolated early manifestation of MDS , thrombocytopenia was present at the time of diagnosis ofMDS in case 2. As his PAIgG level was high, he might be diagnosed as HIV-related thrombocytopenia without evaluation of bone marrow findings. There are recent reports that megakaryocytes express CXCR4 and CD4 (17). It becomes important to evaluate the role of direct infection of these cells by HIV. It is possible that some of the patients diagnosed as HIV-related thrombocytopenia may be MDS.
Wesuggest that HIV infection induces MDS which results from the direct influence on HPC and MDS contributes to peripheral pancytopenia through ineffective hematopoiesis. When peripheral blood cytopenia is observed in patients with AIDS, MDS should be included in the differential diagnosis. 
